The most prevalent ERα mutation is a substitution of the amino acid Y537 in S, N or C (a Y537D mutation was also observed in one patient) with a prevalence reaching 60% of mutations detected in metastatic breast cancer samples [29,31]. This evidence concerns the gene ESR1 and breast cancer.